PHARMACY

Retail Clinician Magazine CARE Awards 2008 sends out call for entries

BY Adam Kraemer

NEW YORK In conjunction with its partners at the Convenient Care Association, The Drug Store News Group/Retail Clinician magazine will honor three convenient care practitioners with the first-ever Retail Clinician CARE (Clinician Awards for Retail Excellence) Award.

Created to honor in-store clinicians for excellence in patient care, the CARE Award is currently accepting nominations. “Do you or a member of your clinic team have an amazing story in patient care? Have you ever done something really unique that made a major impact in one of your patient’s lives?” asked Rob Eder, editor in chief of Drug Store News/Retail Clinician. “These are the kinds of stories we’re looking for.”

In addition to the CARE award plaque, winners will be featured on the cover of the Winter 2008 edition of Retail Clinician magazine, and Retail Clinician magazine will make a donation in their names to the charities of their choosing.

Winners will be announced live on site at the Retail Clinician Education Conference, at a special awards reception, Monday, Aug. 11. Presented by Retail Clinician in association with Drug Store News, and the CCA, RCEC will bring together retail clinicians from across the country to fine tune their skills, while earning up to 16.25 CE/CME credits and learning about the latest products and services the industry has to offer. The keynote speaker is the esteemed Loretta Ford, the co-creator of the NP role.

Nominations can be sent in a note or email including name, the name of the award nominee, where he or she works, and a brief explanation of why the nomination should be considered, to Rob Eder, editor in chief, Retail Clinician, Lebhar Friedman Inc., 425 Park Avenue, New York, NY 10022, [email protected]. Only nurse practitioners and physician assistants currently working in a retail-based convenient care clinic locations are eligible.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Study: pharmacist monitoring can help hypertension

BY Alaric DeArment

SEATTLE An experiment by the Seattle-based Group Health Cooperative has found that Web-based monitoring by pharmacists can help control hypertension.

It found that 56 percent of patients assigned home blood pressure monitoring, Web site training and Web-based pharmacist care experienced increases in control of blood pressure. Those who received the blood pressure monitoring and Web site training only did not experience a significant increase.

The study involved 778 patients ages 25 to 75 in three groups with uncontrolled essential hypertension and Internet access between June 2005 and December 2007.

Results of the study appeared in Wednesday’s issue of the Journal of the American Medical Association.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Genzyme, Isis complete license agreement for cholesterol drug

BY Alaric DeArment

CAMBRIDGE, Mass. Genzyme and Isis Pharmaceuticals announced Tuesday that they had finished a license and collaboration agreement for mipomersen, a drug candidate designed for patients with high cholesterol.

Under the agreement, Genzyme will pay Isis $175 million in licensing fees. Isis will contribute up to $175 million for development. After that, the two companies will share development costs. Isis may also receive up to $1.5 billion in commercial, development and regulatory milestone payments. Genzyme will have preferred access to future drugs that Isis develops for rare diseases and diseases affecting the central nervous system.

The companies will share profits for the drug, with Genzyme receiving 70 percent and Isis receiving 30 percent. They will split profits equally once revenues on mipomersen reach $2 billion. Genzyme will also be responsible for funding sales and marketing until revenues can cover them.

“Mipomersen is an innovative treatment that has the potential to change the standard of care for severely ill patients whose needs cannot be addressed by current cholesterol-lowering therapies,” said Henri A. Termeer, Genzyme’s chairman and chief executive officer.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES